精确针对性治疗PCOS:新兴药物,转化挑战和未来的机会
Xinhong Wu1, Wei Yi1, Xiawen Liu1
1Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, The State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
多囊卵巢综合征 (PCOS) 治疗掩盖了症状,但没有修复核心周期. 精准医学为PCOS提供了新的向疗法,重点关注真正疾病修饰的潜在机制.
科学领域:
- 内分泌学和生殖医学 繁殖医学
- 药理学和治疗学 药理学和治疗学
- 遗传学和基因组学 遗传学和基因组学
背景情况:
- 多囊性卵巢综合征 (PCOS) 涉及胰岛素抵抗和高雄性质的有害循环.
- 目前的PCOS治疗提供了症状缓解,但没有解决核心病理生理学,可能会带来代际风险.
- 对于针对PCOS基本机制的疾病修饰性治疗非常需要.
研究的目的:
- 系统地审查转向PCOS基于机制的精确医学的范式转变.
- 分析新兴的精确向疗法,以解决PCOS中的特定病理节点.
- 探索天然产品和网络药理学在PCOS管理中的潜力.
主要方法:
- 对PCOS新兴精确向疗法的系统评估.
- 针对葡萄糖毒性和BAT-卵巢轴的代谢调节剂 (GLP-1RAs,SGLT2i,BAT激活剂) 的分析.
- 对神经内分泌调节剂 (NK3R抗剂) 和雄激素合成抑制剂 (Artemisinins) 的审查.
- 通过多目标调制的网络药理探索自然产品.
- 转化挑战的评估,包括长期的生殖和后代安全.
主要成果:
- 新兴疗法针对特定的PCOS病理节点:代谢调节,神经内分泌调节和雄激素合成.
- 像GLP-1RAs和SGLT2i这样的代谢调节剂,以及BAT激活剂,为管理PCOS提供了新的途径.
- NK3R对抗剂在调节过度活跃的GnRH脉冲发生器方面表现有前途,而阿尔特米西宁则提供创新的雄激素抑制.
- 自然产品药理网络通过多目标效应提出了一种全面的PCOS管理策略.
- 仍然存在关键的转化挑战,特别是确保长期的生殖和后代安全.
结论:
- 精准医学代表了PCOS治疗的范式转变,超越了症状管理.
- 针对特定病理生理节点的向疗法有可能在PCOS中实现真正的疾病修饰.
- 自然产品,通过网络药理学,为全面的PCOS管理提供了希望.
- 建立长期的安全性对于成功转化新型PCOS疗法至关重要.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:27An Emerging Target Paradigm to Evoke Fast Visuomotor Responses on Human Upper Limb Muscles
Published on: August 25, 2020
相关概念视频
Drug Therapy
Antianxiety Medications
Targeted Cancer Therapies
There are several types of targeted therapies against...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Emerging Adulthood
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
